Molecular analysis of excised tumors demonstrated that the treatment reduces tumor growth due to upregulation of forkhead box O1 (FOXO1) and NFKBIA (IκBα), thus activating apoptosis and potentially inhibiting NF-κB activity. Here, NFKBIA is linked to neoplasm.